FindTrial
Sign In

Rule-Based Closed Loop System for Type 1 Diabetes Control

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01614496
Enrollment
Unknown
Registered
2012-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2013-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

The aim of the study is to assess the efficacy and safety of a Rule-based Closed Loop system, using subcutaneous way, for the overnight and prandial glucose control in type 1 diabetic subjects. Ten subjects will be enrolled and they will participate in a cross-over study with a control night, using their usual insulin pump pattern, and with a experimental night, being controlled for the closed loop system. Each night includes the overnight control and prandial control of the breakfast. The system proposes an insulin dose every 5 minutes according with the value of glucose displayed by the continuous glucose monitoring system.

Interventions

OTHERAlgorithm for insulin administration

Sponsors

Corporacion Parc Tauli
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* Type 1 Diabetes * Insulin pump treatment * Undetectable C-Peptide

Exclusion criteria

* Autonomous system neuropathy

Design outcomes

Primary

MeasureTime frame
Time spent with glucose in the target range—

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026